The CDK6 gene helps control when cells grow and divide. If it does not work as expected, cell growth can become poorly regulated, which may affect development and can contribute to some cancers or, in rare inherited conditions, differences in growth and brain development. This gene plays an important role in tissues that need steady cell renewal, including blood forming cells. CDK6 is better known in medicine than in popular culture because it is a target for several cancer medicines.
What is a gene?
Genes are sections of DNA that give cells instructions for making molecules or managing activities in the body. Some carry the directions for producing proteins, which are the parts of cells that do much of the work. Others are used mainly to regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you react to food, stress, or medicines. For a deeper look at this subject, you can find more in the LearnHub.
Overview
CDK6Gene function
What if the gene works
The CDK6 gene helps control when cells grow and divide. It is especially important in blood-forming tissues and supports normal development by keeping the timing of cell division more controlled.
Risk
What if the gene does not work
More disruptive variants can cause primary microcephaly, often with developmental delay or eye findings. Milder variants may cause a less marked picture, and some altered versions of the CDK6 gene are also linked to low platelet counts.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for a pathogenic or loss of function variant in the CDK6 gene. CDK6 is being studied as a cancer drug target, including in work on CDK4/6 inhibitors, but these medicines are not chosen based on inherited CDK6 variants.
Conditions associated with CDK6
Gene function
What if the gene works
The CDK6 gene helps cells decide when to grow and divide. It is most active in the early steps of the cell cycle, when a cell gets ready to copy its DNA. Understanding what the CDK6 gene does in the body helps explain how normal cell growth stays orderly over time.
The CDK6 gene helps set the pace for the early part of the cell cycle, when a cell prepares to copy its DNA. It helps cells move forward only after the right growth signals are present.
CDK6 works with partner proteins called cyclins to turn outside growth messages into action inside the cell. This links everyday signals from nearby tissues to controlled cell renewal.
Its protein adds a small chemical tag to key control proteins, which changes how strongly they hold back cell division. This helps switch on the genes a cell needs before it starts copying its DNA.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Understanding how CDK6 gene variants affect protein function starts with the fact that different DNA changes can weaken the protein in different ways. Some variants slightly reduce enzyme activity or make the protein less stable, while more disruptive variants can stop it from binding key partners or lead to little or no working protein being made. This range can change cell cycle control and, in disease linked variants, may influence how early and how strongly features appear.
How variants are linked to conditions
Rare inherited variants in both copies of the CDK6 gene can cause a form of primary microcephaly. Among the best-established CDK6 gene variants linked to conditions, affected babies are born with a smaller-than-expected head size, and some children may also have developmental delay or growth differences. Separately, changes in the CDK6 gene that arise only in tumor cells have been reported in some cancers, which is different from an inherited CDK6-related diagnosis.
A variant is not necessarily a diagnosis
Variants in DNA are a usual part of human biology and are widely found across the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. Sometimes, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the CDK6 gene. If you have a CDK6 change or a family history that raises concern, a doctor or genetic counselor can help explain what it may mean for your personal risk.
Inheritance of CDK6 variants
The CDK6 inheritance pattern can differ depending on the condition linked to the variant. For the best described brain growth condition related to the CDK6 gene, inheritance is autosomal recessive, which means a child inherits one altered copy from each parent and the parents are usually unaffected carriers. Some other CDK6-related findings have been reported with a single altered copy, so in those situations inheritance may follow an autosomal dominant pattern, meaning an affected parent can pass the variant to a child. Sons and daughters can inherit CDK6 variants equally because the CDK6 gene is on chromosome 7.
What does my CDK6 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for CDK6, though this understanding can change as research develops. If you have a specific CDK6 result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your result and family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the CDK6 gene, doctors use genetic testing for CDK6 variants on a blood or saliva sample. The lab reads the gene’s DNA code and looks for differences. Results may show a variant linked to disease, a harmless variant, or one whose meaning is not yet clear.
When should I consider getting a genetic test?
There is not yet a widely established reason for most people to have genetic testing focused only on the CDK6 gene. Testing decisions are usually based on your personal health history, family history, and whether a doctor or genetic counselor thinks a broader gene panel would be more useful.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies by the condition and the kind of variant present. Over time, lifestyle, environment, age, and medical history also affect how the body functions. In some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. Because of this, the same medication may work better for one person than another, or may cause more or fewer side effects. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies links between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. If you want to learn more about this topic, additional information is available in the LearnHub.
Drugs influenced by the CDK6 gene
When should I seek medical advice?
This gene is not currently used in a broadly confirmed way to predict how most medicines will work, so general questions about side effects, treatment changes, or new symptoms are best discussed with your doctor. CDK6 has been studied mainly as a treatment target in some cancers, rather than as a gene doctors use to guide routine medication choices.
History
CDK6 emerged in the early 1990s as scientists were mapping the family of human cyclin dependent kinases, a group of genes that changed how researchers understood cell division. It was identified soon after closely related genes such as CDK4, during a period when cancer biology was rapidly shifting toward the study of cell cycle control. From these first observations, research expanded steadily. Work on the CDK6 gene helped establish that problems in these pathways could contribute to uncontrolled cell growth, which shaped modern cancer research. Interest in the CDK6 gene grew further when drugs aimed at CDK4 and CDK6 entered cancer treatment, turning a basic research finding into a clinical milestone. Today, CDK6 is recognized as part of that broader story linking gene discovery to targeted therapy.